Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's metadata now omits the study's disease label and genetics-related topic references (e.g., 'Multiple myeloma', 'related topics:', and 'MedlinePlus Genetics'), reducing explicit disease and genetics associations on the page.
    Difference
    0.2%
    Check dated 2026-09-06T22:39:35.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now displayed, replacing the previous v3.6.5. This indicates a minor metadata update to the page rather than any changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:20.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now lists 'Multiple myeloma' as a keyword and adds a 'Related topics' section with MedlinePlus Genetics, expanding contextual references for users.
    Difference
    0.2%
    Check dated 2026-08-23T20:04:19.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-08-09T10:54:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing Revision: v3.6.3. This change reflects a platform update rather than any alteration to the study details or results.
    Difference
    0.1%
    Check dated 2026-07-25T18:09:17.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page no longer includes the term 'Multiple myeloma' and omits the 'related topics' section and the 'MedlinePlus Genetics' resource. This changes how the study's disease focus and related informational materials are presented.
    Difference
    0.2%
    Check dated 2026-07-11T16:46:10.000Z thumbnail image

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.